ARYA Sciences Acquisition Corp II (58) | Uncategorized (9)
Recent Contracts
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934
(Filed With SEC on March 1, 2022)
-
Amendment No. 1 to Business Combination Agreement, dated as of October 2, 2020, by and between ARYA Sciences Acquisition Corp II and Cerevel Therapeutics, Inc
(Filed With SEC on March 24, 2021)
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
(Filed With SEC on March 24, 2021)
-
Offer Letter, dated August 18, 2019, by and between Cerevel Therapeutics, LLC and Mark Bodenrader
(Filed With SEC on November 16, 2020)
-
Amendment No. 1 to Business Combination Agreement, dated October 2, 2020
(Filed With SEC on October 5, 2020)
-
Letter Agreement among the Company, the Sponsor and the Companys officers and directors
(Filed With SEC on June 9, 2020)
-
Specimen Unit Certificate
(Filed With SEC on May 29, 2020)
-
Form of Indemnity Agreement
(Filed With SEC on May 29, 2020)
-
Form of Letter Agreement between the Registrant, the Sponsor and each director and officer of the Registrant
(Filed With SEC on May 29, 2020)